InsiderClue
Stocks · Health care · Pharmaceutical Preparations

HARROW, INC.

HROW Clue Score59
United States Fiscal year ends December CIK 0001360214 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Amir Shojaei
14 Aug 2026
Chief Scientific Officer
Sold after exercise
11,250
$40.00
$450.00K
Lauren P Silvernail
18 May 2026
Director
Buy
1,000
$31.00
$31.00K
Adrienne L Graves
18 May 2026
Director
Buy
1,000
$31.07
$31.07K
Andrew R. Boll
14 May 2026
President and CFO
Buy
3,500
$29.90
$104.65K
Mark L Baum
14 May 2026
Chief Executive Officer
Buy
10,000
$30.20
$302.00K
Opaleye Management Inc.
4 Mar 2026
10% owner
Sell indirect
4,263
$39.67
$169.12K
Opaleye Management Inc.
4 Mar 2026
10% owner
Sell indirect
134,000
$39.67
$5.32M
Opaleye Management Inc.
3 Mar 2026
10% owner
Sell indirect
1,309
$39.15
$51.25K
Opaleye Management Inc.
3 Mar 2026
10% owner
Sell indirect
59,000
$39.15
$2.31M
Opaleye Management Inc.
27 Feb 2026
10% owner
Sell indirect
5,000
$54.18
$270.90K
Opaleye Management Inc.
6 Jan 2026
10% owner
Sell indirect
20,000
$53.35
$1.07M
Mark L Baum
12 Dec 2025
Chief Executive Officer
Exercised, kept
180,000
$3.95
$711.00K
Andrew R. Boll
12 Dec 2025
President and CFO
Exercised, kept
60,000
$3.95
$237.00K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 357,909
History held since 28 Apr 2008